An investigation of the possible interaction of clomethiazole with glutamate and ion channel sites as an explanation of its neuroprotective activity

Pharmacology and Toxicology

Volumn 83, Issue 2, 1998, Pages 90-94

  Green, A Richard ^a,c   Misra, Anil ^a   Hewitt, Kimberley E ^a   Snape, Mike F ^a   Cross, Alan J ^b  

^a Astra Arcus   (United Kingdom)

^b Astra Arcus USA   (United States)

^c Astra Arcus   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALCIUM CHANNEL; CLOMETHIAZOLE; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; INOSITOL PHOSPHATE; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID; POTASSIUM CHANNEL; SODIUM CHANNEL;

ARTICLE; BINDING SITE; DRUG ACTIVITY; HYDROLYSIS; LIGAND BINDING; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031712653     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01449.x     Document Type: Article

References (36)

1. Baldwin, H. A., J. L. Williams, M. Snares, T. Ferreira, A. J. Cross & A. R. Green: Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. Brit. J. Pharmacol. 1994, 112, 188-194.
2. Butcher, S. P., R. Bullock, D. I. Graham & J. McCulloch: Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 1990, 21, 1727-1733.
3. 3H] tolyl) guanidine labels more than one site in rat forebrain. Eur. J. Pharmacol. 1992, 217, 149-152.
4. Court, J. A., C. J. Fowler, J. M. Candy, P. R. Hoban & C. J. Smith: Raising the ambient potassium ion concentration enhances carbachol stimulated phosphoinositide hydrolysis in rat brain hippocampal and cerebral cortical miniprisms. Naunyn - Schmiedebergs Arch. Pharmacol. 1986, 334, 10-16.
5. 3H]-batrachotoxin-A-20α-benzoate binding in a vesicular preparation from guinea pig cerebral cortex. Mol. Pharmacol. 1983, 23, 350-358.
6. Cross, A. J., A. Misra, A. Sandilands, M. J. Taylor & A. R. Green: Effect of chlormethiazole, dizocilpine and pentobarbital on harmaline-induced increase of cerebellar cyclic GMP and tremor. Psychopharmacology 1993a, 111, 96-98.
7. Cross, A. J., M. F. Snape & A. R. Green: Chlormethiazole antagonises seizures induced by N-methyl-D-aspartate without interacting with NMDA receptor complex. Psychopharmacology 1993b, 112, 403-406.
8. Cross, A. J., J. A. Jones, M. Snares, K.-G. Jostell, U. Bredberg & A. R. Green: The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity. Brit. J. Pharmacol. 1995, 114, 1625-1630.
9. Fariello, R. G., G. T. Golden, C. C. Smith & P. F. Reyes. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist. Epilepsy Res. 1989, 3, 206-213.
10. Ferkany, J. W., R. Zaczek & J. T. Coyle: Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature 1982, 298, 757-759.
11. 3H glibenclamide binding sites in cardiac ventricular membranes. Biochem. Biophys. Res. Commum. 1990, 167, 1400-1405.
12. Gill, R. & D. Lodge: Pharmacology of AMPA antagonists and their role in neuroprotection. Int. Rev. Neurobiol. 1997, 40, 197-232.
13. ®) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy. Pharmacol. Ther. 1998, in press.
14. Green, A. R., E. M. Davies, H. J. Little, M. A. Whittington & A. J. Cross: Action of chlormethiazole in a model of alcohol withdrawal. Psychopharmacology 1990, 102, 239-242.
15. Guidotti, A., G. Biggio & E. Costa: 3-Acetylpyridine: a tool to inhibit the tremor and increase in cGMP content in cerebellar cortex elicited by harmaline. Brain Res. 1975, 96, 201-205.
16. 3H]-5-fluorowillardiine binding in rat brain. Brit. J. Pharmacol. 1995a, 116, 2033-2039.
17. 3H]-AMPA to rat brain synaptic membranes : effects of a series of structural analogues of the non-NMDA receptor agonist willardiine. Neuropharmacology 1995b, 34, 405-410.
18. Heggli, D. A., A. Aamodt & D. Malthe-Sorenssen: Kainic acid neurotoxicity; effect of systemic injection on neurodegenerationtransmitter markers in different brain regions. Brain Res. 1981, 230, 253-262.
19. 3H-CNQX binds with equal affinity to two agonist states of quisqualate receptors. Biochem. Pharmacol. 1989, 38, 3207-3212.
20. Hunter, A. J.: Calcium antagonists: their role in neuroprotection. Int. Rev. Neurobiol. 1997, 40, 95-108.
21. 2+ mobilisation in rat cerebeller neurones. Eur. J. Pharmacol. 1990, 186, 363-365.
22. Klein, M., & J. Musacchio: High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents. J. Pharmacol Exp. Therap. 1989, 251, 207-215.
23. 3H]-(+)-PN 200-110 binding to dihydropyridine receptor associated with calcium channels in rat cerebral cortex and heart. Life Sci. 1984, 35, 721-731.
24. Lyden, P.: GABA and neuroprotection. Int. Rev. Neurobiol. 1997, 40, 233-258.
25. 1 receptor. Brit. J. Pharmacol. 1993, 110, 470-476.
26. MacGregor, D. G., D. I. Graham & T. W. Stone: The attenuation of kainate-induced neurotoxicity by clomethiazole and its enhancement by dizocilpine, muscimol and adenosine receptor agonists. Exp. Neurol. 1997, 148, 110-123.
27. Nicoletti, F., V. Bruno, A. Copani, G. Casabona & T. Knopfel: Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci 1996, 19, 267-271.
28. Obrenovitch, T. P.: Sodium and potassium channel modulators : their role in neuroprotection. Int. Rev. Neurobiol. 1997, 40, 109-135.
29. Paxinos, G. & C. Watson: The rat brain in stereotaxic co-ordinates. Academic Press, New York, 1986.
30. 3H]-MK-801) binding to rat cortical N-methyl-D-asparate receptor by polyamines. Mol. Neuropharmacol. 1990, 1, 31-35.
31. Schoepp, D. D. & J. P. Conn: Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci. 1993, 14, 13-20.
32. Shuaib, A., S. Ijaz & R. Kanthan: Clomethiazole protects the brain in transient forebrain ischaemia when used up to 4h after the insult. Neurosci. Letts. 1995, 197, 109-112.
33. Small, D. L. & A. M. Buchan: NMDA antagonists: their role in neuroprotection. Int. Rev. Neurobiol. 1997, 40, 137-171.
34. Takahashi, H., J. R. Kirsch, K. Hashimoto, E. D. London, R. C. Koehler & R. J. Trystman: PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischaemia in cats. Stroke 1995, 26, 1676-1682.
35. Thorén, P. & M. Sjölander: Chlormethiazole attenuates the derangement of sensory evoked potential (SEP) induced by i.c.v. administration of NMDA. Psychopharmacology 1993, 111, 256-258.
36. Wagner, J. A., A. M. Snowman, A. Biswas, B. M. Olivera & S. H. Snyder: ω-Conotoxin GVIA binding to a high affinity receptor in brain: characterisation, calcium sensitivity and solubilsation. J. Neurosci. 1988, 81, 3354-3359.